Rallybio (RLYB) Common Equity (2020 - 2026)
Rallybio (RLYB) posted Common Equity of $94.5 million for Q2 2026, up 105.6% from $45.96 million a year earlier and up 88.0% from the prior quarter.
Powered by 
Analysis
Rallybio (RLYB) Common Equity (2020 - 2026) Analysis & Trends
At the end of FY2025, Rallybio's Common Equity came in at $57.96 million, down 6.0% from FY2024.
- Annual Common Equity has declined for four consecutive years, with a five-year compound annual growth rate of -15.7% (FY2020 to FY2025).
- In prior years, Rallybio's Common Equity was $61.65 million in FY2024 (-41.9%), $106.18 million in FY2023 (-37.3%), $169.32 million in FY2022 (-3.6%) and $175.6 million in FY2021 (+29.1%).
- The Q2 2026 figure stands as the highest quarterly Common Equity since Q4 2023.
- On a year-over-year basis, Common Equity increased in 1 of the last eight quarters, with an average decline of 10.6%.
- The strongest year-over-year quarter for Common Equity in the past five years was Q2 2026, with growth of 105.6%; the weakest was Q3 2024, with a decline of 42.7%.
- According to Business Quant data, Common Equity for the three prior quarters was $50.28 million (Q1 2026), $57.96 million (Q4 2025) and $63.03 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Rallybio | 90.48 Mn | 90.48 Mn | - | 94.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 94.50 Mn |
| Mar 31, 2026 | 50.28 Mn |
| Dec 31, 2025 | 57.96 Mn |
| Sep 30, 2025 | 63.03 Mn |
| Jun 30, 2025 | 45.96 Mn |
| Mar 31, 2025 | 54.07 Mn |
| Dec 31, 2024 | 61.65 Mn |
| Sep 30, 2024 | 70.82 Mn |
| Jun 30, 2024 | 80.02 Mn |
| Mar 31, 2024 | 89.16 Mn |
| Dec 31, 2023 | 106.18 Mn |
| Sep 30, 2023 | 123.58 Mn |
| Jun 30, 2023 | 139.26 Mn |
| Mar 31, 2023 | 155.20 Mn |
| Dec 31, 2022 | 169.32 Mn |
| Sep 30, 2022 | 131.94 Mn |
| Jun 30, 2022 | 147.85 Mn |
| Mar 31, 2022 | 163.04 Mn |
| Dec 31, 2021 | 175.60 Mn |
| Sep 30, 2021 | 186.49 Mn |
API Access
Rallybio Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=RLYB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "RLYB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=RLYB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();